With the rising popularity of semaglutide for weight loss and diabetes management, many people are turning to telehealth services like Henry Meds for a more convenient, lower-cost option
The addition of glucagon receptor activation introduces direct thermogenic and lipolytic effects that neither GLP-1 nor GIP agonism provides alone, creating a mechanism that, in some ways, bridges the gap between the direct fat-targeting approach of AOD 9604 and the systemic metabolic reprogramming of tirzepatide
Mechanism of action: Activates GLP-1 receptors in the brain, gut, and pancreas Reduces appetite and food cravings Slows gastric emptying you feel full longer Stimulates insulin release, suppresses glucagon Improves blood sugar regulation FDA-approved brand names: Wegovy 2.4mg weekly, approved for chronic weight management Ozempic approved for type 2 diabetes
Keep sealed until point of use
This is not a job for a weight-loss clinic alone